Shaomeng Wang,Haibin Zhou,Jianfeng Lu,Liu Liu,Yi Sun,Denzil Bernard
申请号：
US16496974
公开号：
US20200109167A1
申请日:
2018.03.28
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Compounds of formula (I) as inhibitors of DCN1 and compositions containing the same are disclosed. Methods of using the DCN1 inhibitors in the treatment of diseases and conditions wherein inhibition of DCN1 provides a benefit, like oxidative stress-related diseases and conditions, neurodegenerative diseases and conditions, metabolic disorders, and muscular nerve degeneration, also are disclosed.
